Form D — Rani Therapeutics Holdings, Inc.
0001231919-25-000450 · filed Nov 10, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $60,255,052
- Reported amount sold
- $60,255,052
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Rani Therapeutics Holdings, Inc.
- CIK
- 1856725
- Entity
- Corporation
- Jurisdiction
- CALIFORNIA
- Year incorporated
- 2021
- Address
- 2051 RINGWOOD AVENUE
SAN JOSE, California 95131 - Phone
- (408) 457-3700
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Talat Imran · Executive OfficerSAN JOSE, California Find on LinkedIn ↗
-
Svai Sanford · Executive OfficerSan Jose, California Find on LinkedIn ↗
-
Mir Imran · DirectorSan Jose, California Find on LinkedIn ↗
-
Dennis Ausiello · DirectorSan Jose, California Find on LinkedIn ↗
-
Jean-Luc Butel · DirectorSan Jose, California Find on LinkedIn ↗
-
Mir Hashim · Executive OfficerSan Jose, California Find on LinkedIn ↗
-
Lisa Rometty · DirectorSan Jose, California Find on LinkedIn ↗
-
Abraham Bassan · DirectorSan Jose, California Find on LinkedIn ↗
-
Vasudev Bailey, M.D. · DirectorSan Jose, California Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗